Media News

APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival

GENEVA, Nov. 21, 2022 /PRNewswire/ -- RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (RLFTD) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent protected products in selected specialty, rare and ultra-rare disease areas on a global basis, today announced that its wholly owned subsidiary APR Applied Pharma Research SA ("APR") has been nominated as a...

Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation’s Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals

VELDONA® interferon-alpha formulation has shown potential as a treatment candidate for feline chronic gingivostomatitis and canine atopic dermatitis Ainos advances its product pipeline as it targets commencing clinical studies during the second quarter of 2023 SAN DIEGO, Nov. 21, 2022 /PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on the development...

OLON, INTERNATIONAL API SUPPLIER, RELEASES THE NEW SUSTAINABILITY REPORT 2022 CONFIRMING THE PROGRESS OF ITS SUSTAINABILITY IN THE FOCUS AREAS OF ENVIRONMENT, SUPPLY CHAIN, PEOPLE, COMMUNITY ENGAGEMENT, PRODUCTION

"Our ambition is to promote a more sustainable production of APIs, meeting the highest standards of quality" Paolo Tubertini, CEO of the Group, commented "To achieve this, we are investing in people, in innovation and technology processes, endorsing the sustainable development goals proposed by the UN 2030 Agenda" MILAN, Nov. 21,...

Nona Biosciences Enters into HCAb Based Drug Discovery Collaboration Agreement with Dragonfly Therapeutics

CAMBRIDGE, Mass., Nov. 21, 2022 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited committed to providing a total solution from "Idea to IND" ("I to ITM"), today announced that it has entered into a collaboration agreement with Dragonfly Therapeutics based on Nona's proprietary fully human heavy chain only antibody (HCAb)...

Lianhua Respiratory Health Products to Assure the Smooth Holding of Hainan International Health Industry Expo

SHIJIAZHUANG, China, Nov. 21, 2022 /PRNewswire/ -- The 6th Hainan International Health Industry Expo kicked off on November 18th, in Haikou City, China's Hainan Province. With the theme of "Construct a Global Health System, Draw a Beautiful Future for Hainan Free Trade Port", this year's event will hold 30 high-level forums, famous medical scientists, doctors, experts, and entrepreneurs from...

Jiangsu Recbio Technology Co., Ltd. Increases Production For The First Phase Of Manufacturing Facility With A Maximum Annual Output Of 20 Million Doses Of Recombinant HPV 9-Valent Vaccine

TAIZHOU, China, Nov. 21, 2022 /PRNewswire/ --  (the "Company", together with its subsidiaries, the "Group") on voluntary basis. The board of directors of the Company (the "Board") is pleased to announce that in order to meet the rapidly growing market demand for HPV 9-valent vaccines in China and the international market,...

Where your days begin again: Medical Korea

NEW YORK and SEOUL, South Korea, Nov. 21, 2022 /PRNewswire/ -- The number of international medical tourists visiting Korea increased by 25% from 110,000 in 2020 to 140,000 in 2021 despite the impact of the COVID-19 pandemic. Medical Korea shines in Times Square in Manhattan, New York. Korea is one of the most...

BGI Group Signs MOUs in Indonesia to Support Genomics Development

SHENZHEN, China, Nov. 21, 2022 /PRNewswire/ -- BGI Group signed three Memorandum of Understandings (MOUs) in the lead up to the G20 Summit in Bali with the Indonesian Ministry of Health, the University of Indonesia and the Del Institute of Technology (Institut Teknologi Del). The MOUs cover genomics development initiatives, construction of related laboratories, and joint research and personnel...

Abbott Launches Panbio(TM) HIV Self Test at Retail, Increasing Access to Faster, Reliable and Discrete Testing at Home

Over-the-counter HIV self-tests can help overcome barriers, including healthcare access and stigma associated with HIV testing, while helping to expand screening Fast, private and easy-to-use at home, Panbio™ HIV Self Test is a fingerstick blood test that detects HIV-1 and HIV-2 antibodies in 15-20 minutes Panbio is highly accurate and reliable, demonstrating a 95.1% sensitivity and 99.6% specificity...

MEDICA 2022 Newcomer: Scivita Medical celebrates trade show success and the strategy of “globalization”

DUSSELDORF, Germany, Nov. 21, 2022 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ("Scivita Medical") looks back on an exciting week at the trade fair. Scivita Medical was able to announce a strategic cooperation with FUJIFILM Europe B.V. ("Fujifilm") at this year's MEDICA, in addition to presenting their innovative endoscopes and medical imaging technology. Under a supply...